Jaime Bartushak
Director of Finance/CFO bei CITIUS PHARMACEUTICALS, INC.
Vermögen: 54 137 $ am 31.03.2024
Profil
Jaime Bartushak is the founder of Leonard-Meron Biosciences, Inc., which was founded in 2013.
He held the title of Chief Financial Officer from 2013 to 2017.
Currently, Mr. Bartushak is the Chief Financial & Business Officer at Citius Pharmaceuticals, Inc. since 2017.
Mr. Bartushak has an educational background, having completed undergraduate and graduate degrees at New Jersey Institute of Technology.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 19.01.2024 | 60 353 ( 0,04% ) | 54 137 $ | 31.03.2024 |
Aktive Positionen von Jaime Bartushak
| Unternehmen | Position | Beginn |
|---|---|---|
| CITIUS PHARMACEUTICALS, INC. | Director of Finance/CFO | 27.11.2017 |
Ehemalige bekannte Positionen von Jaime Bartushak
| Unternehmen | Position | Ende |
|---|---|---|
Leonard-Meron Biosciences, Inc.
 Leonard-Meron Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leonard-Meron Biosciences, Inc. develops and commercializes critical care products. It offers Mino-Lok, an antibiotic lock solution used to treat patients with catheter-related bloodstream infections. The company was founded by Myron Z. Holubiak in October 2013 and is headquartered in Cranford, NJ. | Founder | 01.11.2017 |
Ausbildung von Jaime Bartushak
| New Jersey Institute of Technology | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CITIUS PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Leonard-Meron Biosciences, Inc.
Leonard-Meron Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leonard-Meron Biosciences, Inc. develops and commercializes critical care products. It offers Mino-Lok, an antibiotic lock solution used to treat patients with catheter-related bloodstream infections. The company was founded by Myron Z. Holubiak in October 2013 and is headquartered in Cranford, NJ. | Health Technology |
